Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0RT6C
|
|||
Drug Name |
PMID27376512-Compound-Table1Example8
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
IKERCHEM S L [ESUNIV DEL PA S VASCO [ES]
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H21NO7
|
|||
Canonical SMILES |
COC1=CC2=C(C(=C1)OC)C(=CN2CC(=O)C3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)O)O
|
|||
InChI |
1S/C24H21NO7/c1-31-15-9-17-24(23(10-15)32-2)16(13-3-5-18(26)20(28)7-13)11-25(17)12-22(30)14-4-6-19(27)21(29)8-14/h3-11,26-29H,12H2,1-2H3
|
|||
InChIKey |
VZIMIRNNOGRJFC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA [cytosine-5]-methyltransferase 1 (DNMT1) | Target Info | Inhibitor | [1] |
Target's Patent Info | DNA [cytosine-5]-methyltransferase 1 (DNMT1) | Target's Patent Info | [1] | |
KEGG Pathway | Cysteine and methionine metabolism | |||
Metabolic pathways | ||||
MicroRNAs in cancer | ||||
Pathwhiz Pathway | Methionine Metabolism | |||
Pathway Interaction Database | Regulation of retinoblastoma protein | |||
Reactome | PRC2 methylates histones and DNA | |||
NoRC negatively regulates rRNA expression | ||||
DNA methylation | ||||
WikiPathways | Trans-sulfuration and one carbon metabolism | |||
Retinoblastoma (RB) in Cancer | ||||
One Carbon Metabolism | ||||
Trans-sulfuration pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | DNA methyltransferase inhibitors: an updated patent review (2012-2015).Expert Opin Ther Pat. 2016 Sep;26(9):1017-30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.